Your browser doesn't support javascript.
loading
Deficient cutaneous antibacterial competence in cutaneous T-cell lymphomas: role of Th2-mediated biased Th17 function.
Wolk, Kerstin; Mitsui, Hiroshi; Witte, Katrin; Gellrich, Sylke; Gulati, Nicholas; Humme, Daniel; Witte, Ellen; Gonsior, Melanie; Beyer, Marc; Kadin, Marshall E; Volk, Hans-Dieter; Krueger, James G; Sterry, Wolfram; Sabat, Robert.
Affiliation
  • Wolk K; Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany. Research Center Immunosciences, University Hospital Charité, Berlin, Germany.
  • Mitsui H; Laboratory for Investigative Dermatology, Rockefeller University, New York, New York.
  • Witte K; Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany.
  • Gellrich S; Department of Dermatology and Allergy, University Hospital Charité, Berlin, Germany.
  • Gulati N; Laboratory for Investigative Dermatology, Rockefeller University, New York, New York.
  • Humme D; Department of Dermatology and Allergy, University Hospital Charité, Berlin, Germany.
  • Witte E; Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany.
  • Gonsior M; Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany.
  • Beyer M; Department of Dermatology and Allergy, University Hospital Charité, Berlin, Germany.
  • Kadin ME; Department of Dermatology, Boston University, Roger Williams Medical Center, Providence, Rhode Island.
  • Volk HD; Institute of Medical Immunology, University Hospital Charité, Berlin, Germany. Berlin-Brandenburg Center for Regenerative Therapies, University Hospital Charité, Berlin, Germany.
  • Krueger JG; Laboratory for Investigative Dermatology, Rockefeller University, New York, New York.
  • Sterry W; Department of Dermatology and Allergy, University Hospital Charité, Berlin, Germany.
  • Sabat R; Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. Interdisciplinary Group of Molecular Immunopathology, Dermatology/Medical Immunology, University Hospital Charité, Berlin, Germany. Research Center Immunosciences, University Hospital Charité, Berlin, Germany. rob
Clin Cancer Res ; 20(21): 5507-16, 2014 Nov 01.
Article in En | MEDLINE | ID: mdl-25212608
PURPOSE: Primary cutaneous T-cell lymphomas (CTCL) are neoplastic disorders of skin-homing T cells. Affected skin areas show morphologic similarities with alterations in other T-cell-mediated dermatoses. Furthermore, as in atopic dermatitis but in contrast with psoriasis, patients with CTCL are frequently afflicted by cutaneous bacterial infections that support the survival of lymphoma cells. Our aim was to investigate the mechanisms of elevated susceptibility to cutaneous infections in patients with CTCL. EXPERIMENTAL DESIGN: Skin samples from CTCL, psoriasis, and atopic dermatitis patients were used to illuminate the antibacterial competence status and the presence of its modulating cytokines. For substantiation of findings, 3-dimensional epidermis models, isolated and in vitro generated Th-subpopulations, were applied. Parameters were analyzed via qPCR and IHC. RESULTS: CTCL lesions compared with psoriatic lesions presented an impaired upregulation of antibacterial proteins (ABPs), with levels even below those in atopic dermatitis. This was associated with a relative deficiency of the ABP-inducing cytokine IL-17 and a strong presence of the ABP-downregulating cytokine IL-13. The simultaneous presence of the Th17-cell cytokine IL-26 indicated that IL-17 deficiency in CTCL lesions results from functional deviation of Th17 cells. Accordingly, IL-17 but not IL-26 production by Th17 cells in vitro was inhibited by IL-4Rα ligand. Levels of other ABP inducers were comparable between CTCL and psoriasis lesions. The same was true about IL-22/TNF-α targets, including the keratinocyte hyper-regeneration marker K16 and the matrix-degrading enzyme MMP1. CONCLUSION: Our results suggest that the cutaneous bacterial infections in CTCL are caused by impaired ABP induction as consequence of Th2-mediated biased Th17-cell function.
Subject(s)

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Lymphoma, T-Cell, Cutaneous / Th2 Cells / Epidermis / Th17 Cells / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: Germany

Full text: 1 Database: MEDLINE Main subject: Skin Neoplasms / Lymphoma, T-Cell, Cutaneous / Th2 Cells / Epidermis / Th17 Cells / Anti-Bacterial Agents Type of study: Prognostic_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2014 Type: Article Affiliation country: Germany